about
Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-AnalysisEfficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trialsCoronary microvascular dysfunction in the clinical setting: from mystery to realityRisks and complications of coronary angiography: a comprehensive reviewNrf2 protects mitochondrial decay by oxidative stressTreatment of microvascular micro-embolization using microbubbles and long-tone-burst ultrasound: an in vivo study.A new technique for lipid core plaque detection by optical coherence tomography for prevention of peri-procedural myocardial infarction: A case report.Relationship of glycated hemoglobin levels with myocardial injury following elective percutaneous coronary intervention in patients with type 2 diabetes mellitus.Atorvastatin pretreatment diminishes the levels of myocardial ischemia markers early after CABG operation: an observational study.Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection.Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris during percutaneous coronary interventions under an adjunctive antithrombotic therapy with abciximab: design and rationale of the High Intensity TrThird universal definition of myocardial infarction.High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.Recent advances in the diagnosis and treatment of acute myocardial infarctionPredictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins.The Prevalence of Clinically Significant Ischemia in Patients Undergoing Percutaneous Coronary Intervention: A Report from the Multicenter RegistryTroponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention.Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves).Coronary aspirate TNFα reflects saphenous vein bypass graft restenosis risk in diabetic patients.Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosisDoes Pre-Treatment with High Dose Atorvastatin Prevent Microvascular Dysfunction after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome?Effects of intravenous diltiazem in a rat model of experimental coronary thrombotic microembolism.Lack of consensus in biomarker measurement to diagnose PCI-related myocardial infarction.The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary interventionElevated preoperative HMGB1 as predictor of myocardial injury post-percutaneous coronary intervention.A Comparison of Peri-Procedural Myocardial Infarction between Paclitaxel-Coated Balloon and Drug-Eluting Stent on De Novo Coronary Lesions.Establishment of a Novel Mouse Model of Coronary Microembolization.Treating percutaneous coronary intervention-related myocardial injury with metformin.Effects of exercise-based cardiac rehabilitation in patients after percutaneous coronary intervention: A meta-analysis of randomized controlled trials.The impact of a single episode of remote ischemic preconditioning on myocardial injury after elective percutaneous coronary interventionHigh dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.Effect of High-Dose Statin Pretreatment on the Incidence of Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention: Grading the Evidence Through a Cumulative Meta-analysis.Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The 'wait a day' approach might be safer.Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.Adjunctive loading dose of cilostazol in preventing periprocedural myocardial infarction.Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.Statin treatment before percutaneous cononary intervention.
P2860
Q26787236-1E1E59BB-A215-4A62-97BF-B65B7DF5FD3AQ26797400-98678FC5-27E8-4F10-88E0-CB595AB5074DQ26849534-66BC42B2-EF30-4C68-84DB-9C56477ADA6BQ27025085-CC540BA1-8E9F-467A-BDCD-5972604D1786Q28396758-E2C6D105-903E-480D-8CAA-CD86C1BFAA5DQ30412302-7784997C-948E-4246-831F-A51878455D10Q30855302-7892F92C-1E8B-4826-A06B-E4E57F28B37FQ33837952-ED0E2B2E-6696-439D-B520-90BF1F1A9C05Q34081786-DE16B2F0-EE5D-45ED-9B89-0E3480872C04Q34147112-9E629B57-23D3-4EB9-8AF7-0EC7D9368A46Q34276221-3FCC8A26-38C6-4061-84D7-A3F28EDD297EQ34295914-E8ED0A2E-0B3B-49CD-92F8-92C9570F5F39Q34634358-B6988405-056F-4D41-97C2-5569B9B737C6Q34974622-C5A25AFD-2E5B-4B42-B390-A46930F9E9AEQ35626702-10B13C03-036A-4CC6-8061-7F776907AAA6Q35674008-E6379C21-85E2-4DD4-B241-265E3FA7E875Q35731501-CDE6BB3C-82A0-4A77-BA8E-30B6D6EC8504Q35812673-811EA490-B513-4C5B-879C-FA39285FC431Q36219512-C06165DB-FD46-4C44-BB40-94A798200A77Q36576204-44988D6E-7974-43FB-82F3-BE8DE2B04B06Q36649949-D30670A1-62A7-40DA-B6E8-93CA145E9A39Q37136510-EFC31EB0-EC51-4559-AD29-D0E1CAC8A6BFQ37231298-64324C18-B51C-47E3-9FE6-9D07DA30581DQ37323623-9475B267-8E81-423D-8D02-CD99ECE0B33AQ37431525-8E047584-414F-44CE-AC6A-CBD41DAA70BBQ37432890-0B5F0F3B-9D6A-461B-881C-A2234DDC0312Q37438436-E194CED6-3D12-4DDF-AE18-CFF6A5404CF1Q37543544-C233815B-0F26-4B30-8A30-1782772408F9Q37592833-D9A57CD9-310E-4D8D-87FA-E8F7DF79DA2FQ37708122-76377E7D-3297-453C-A994-EAA7CDC2A819Q37719199-105188CD-1B28-4855-B277-E02CAB245D07Q38165881-2CDC3E3F-FCE0-4E49-870E-DC3767F358E4Q38600680-545B138D-5E96-40C1-AD3C-C777464D9D03Q38683249-D4D08610-41C1-442E-950F-939935422E69Q38699009-D9D71D6F-1530-4D58-AD9D-FD67A302DBA8Q39680106-3D8C79C0-4894-4141-A4EC-BCA0AE28F896Q40704357-7B15579D-5F88-4E34-96B2-72BB33E44C0BQ40774012-EC10DA14-42F3-4BEE-B865-4876DD1F2DAEQ40917616-9F4A1A38-1089-4C27-8BB8-07CC021A30C3Q41374557-3FAA8D0B-121E-4EA8-9E9E-AB91F9F80674
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Peri-procedural myocardial injury: 2005 update.
@ast
Peri-procedural myocardial injury: 2005 update.
@en
type
label
Peri-procedural myocardial injury: 2005 update.
@ast
Peri-procedural myocardial injury: 2005 update.
@en
prefLabel
Peri-procedural myocardial injury: 2005 update.
@ast
Peri-procedural myocardial injury: 2005 update.
@en
P2860
P356
P1476
Peri-procedural myocardial injury: 2005 update.
@en
P2093
Joerg Herrmann
P2860
P304
P356
10.1093/EURHEARTJ/EHI455
P577
2005-09-21T00:00:00Z